tiprankstipranks
Advertisement
Advertisement

INSM Stock Latest News

Insmed initiated with an Outperform at Raymond James
The FlyInsmed initiated with an Outperform at Raymond James
1d ago
INSM
Insmed initiated with an Outperform at Raymond James
PremiumThe Fly
Insmed initiated with an Outperform at Raymond James
2d ago
INSM
Insmed price target lowered to $202 from $206 at Mizuho
PremiumThe Fly
Insmed price target lowered to $202 from $206 at Mizuho
3d ago
INSM
Reallocating Capital Beyond HS: Supporting a Buy Rating on Insmed’s Diversified Next‑Generation Pipeline
PremiumRatings
Reallocating Capital Beyond HS: Supporting a Buy Rating on Insmed’s Diversified Next‑Generation Pipeline
3d ago
INSM
Insmed price target lowered to $212 from $213 at BofA
PremiumThe Fly
Insmed price target lowered to $212 from $213 at BofA
3d ago
INSM
Insmed’s phase 2 a ‘clearing event’, says Roth Capital
PremiumThe FlyInsmed’s phase 2 a ‘clearing event’, says Roth Capital
4d ago
INSM
Insmed Halts Brensocatib Development After Phase 2b Failure
Premium
Company Announcements
Insmed Halts Brensocatib Development After Phase 2b Failure
4d ago
8K
INSM
Insmed down 2% at $160 following resumption of trade
Premium
The Fly
Insmed down 2% at $160 following resumption of trade
4d ago
INSM
Insmed trading resumes
PremiumThe Fly
Insmed trading resumes
4d ago
INSM
Insmed to resume trading at 4:30 pm ET
PremiumThe Fly
Insmed to resume trading at 4:30 pm ET
4d ago
INSM
Insmed trading halted, news pending
PremiumThe Fly
Insmed trading halted, news pending
4d ago
INSM
Insmed announces Phase 2b CEDAR study did not meet primary endpoint
PremiumThe Fly
Insmed announces Phase 2b CEDAR study did not meet primary endpoint
4d ago
INSM
Insmed price target raised to $212 from $203 at RBC Capital
PremiumThe FlyInsmed price target raised to $212 from $203 at RBC Capital
4d ago
INSM
Insmed price target raised to $237 from $231 at Barclays
Premium
The Fly
Insmed price target raised to $237 from $231 at Barclays
10d ago
INSM
Insmed upgraded to Overweight from Equal Weight at Morgan Stanley
Premium
The Fly
Insmed upgraded to Overweight from Equal Weight at Morgan Stanley
12d ago
INSM
Insmed price target raised to $245 from $230 at H.C. Wainwright
PremiumThe Fly
Insmed price target raised to $245 from $230 at H.C. Wainwright
16d ago
INSM
Insmed price target raised to $206 from $204 at Mizuho
PremiumThe Fly
Insmed price target raised to $206 from $204 at Mizuho
17d ago
INSM
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/24/2026
PremiumMarket News
Invesco QQQ Trust ETF (QQQ) Daily Update, 3/24/2026
18d ago
NDX
QQQ
Insmed price target raised to $243 from $241 at TD Cowen
PremiumThe Fly
Insmed price target raised to $243 from $241 at TD Cowen
18d ago
INSM
Insmed price target raised to $208 from $205 at Stifel
PremiumThe FlyInsmed price target raised to $208 from $205 at Stifel
18d ago
INSM
Insmed price target raised to $177 from $175 at Wells Fargo
Premium
The Fly
Insmed price target raised to $177 from $175 at Wells Fargo
18d ago
INSM
Insmed price target raised to $213 from $211 at BofA
Premium
The Fly
Insmed price target raised to $213 from $211 at BofA
18d ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >